C03416: HIF-1aDP, A Constitutively-Expressed form of Hypoxia-Inducible Factor 1a

Case ID:
C03416
Disclosure Date:
5/1/1998
C03416: HIF-1aDP, A Constitutively-Expressed form of Hypoxia-Inducible Factor 1a
Technical Details:
It has previously been demonstrated that a truncation of HIF-1alpha after amino acid residue 390 results in a constitutively expressed form of the protein. The purpose of this work was to identify mechanisms by which the half-life of the HIF1alpha protein is modulated as a function of cellular O2 concentration, such that the stability of the protein is greater under hypoxic, relative to non-hypoxic conditions. The strategy employed was to introduce mutations into the protein-coding DNA sequence and to identify mutants, which no longer manifested decreased protein stability under non-hypoxic conditions. This strategy was designed to (1) identify important regions of regulation with the HIF-1alpha molecule; and (2) engineer a constitutively stable form of HIF-1alpha that could be utilized for gene therapy of ischemic cardiovascular disease.
Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Christine Joseph
cjoseph6@jhmi.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum